Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / B••••••

E••••••• C••••••• Acquires B••••••

Add-on acquisitionclosedadd-onannouncement date unknownFact
What happened
Target
B••••••
Platform
E••••••• C••••••• L•••add-on basis: A•••••• acquired E••••••• C••••••• in 2024 and continues to support the company’s growth and evolution of its RTSM platforms and AI capabilities. | published on A•••••• Capital's own news page
Control
Control
Share acquired
unknown
Industry
healthcare / clinic
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • E••••••• C••••••• L•••Platformconfirmed
    “A•••••• acquired E••••••• C••••••• in 2024 and continues to support the company’s growth and evolution of its RTSM platforms and AI capabilities. | published on A•••••• Capital's own news page”
  • A•••••• C•••••• M••••••••• L•Sponsorconfirmed
    “A•••••• acquired E••••••• C••••••• in 2024 and continues to support the company’s growth and evolution of its RTSM platforms and AI capabilities. | published on A•••••• Capital's own news page”
Side not stated
  • A••• M•••••Managementconfirmed
    ““We’re thrilled to be joining the E••••••• team,” said A••• M•••••, Co-Founder and Chief Executive Officer of B••••••.”
  • B••••••Targetconfirmed
    “E••••••• C••••••• L•••, a global leader in randomization and trial supply management (“RTSM”) solutions and a portfolio company of A•••••• Capital Partners, today announced it has acquired B••••••, a Boston-based provider of clinical supply forecasting and planning technology.”
Evidence
“E••••••• C••••••• L•••, a global leader in randomization and trial supply management (“RTSM”) solutions and a portfolio company of A•••••• Capital Partners, today announced it has acquired B••••••, a Boston-based provider of clinical supply forecasting and planning technology.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 17, 2026
E••••••• C••••••• Acquires B•••••• | Private Equity Intelligence | DFX